基于花簇SnS2/ZnCdS异质结构的超灵敏光电化学免疫传感器检测CA199。

IF 4.3 3区 工程技术 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Frontiers in Bioengineering and Biotechnology Pub Date : 2025-06-11 eCollection Date: 2025-01-01 DOI:10.3389/fbioe.2025.1584456
Hui Zhou, Qingqing Guo, Xin Zhang, Tingting Chu, Wen Zhang, Qing Liu, Linlin Cao
{"title":"基于花簇SnS2/ZnCdS异质结构的超灵敏光电化学免疫传感器检测CA199。","authors":"Hui Zhou, Qingqing Guo, Xin Zhang, Tingting Chu, Wen Zhang, Qing Liu, Linlin Cao","doi":"10.3389/fbioe.2025.1584456","DOIUrl":null,"url":null,"abstract":"<p><p>The early and accurate detection of tumor markers is crucial for cancer diagnosis, prognosis, and treatment monitoring. Carbohydrate antigen 199 (CA199), as a key biomarker of pancreatic, gastric, and colorectal cancers, is widely used in the clinical management. The development of sensitive, rapid and cost-effective detection methods for CA199 is of paramount importance in improving early detection rates and patient outcomes. In this study, we present a novel photoelectrochemical (PEC) immunosensor based on a SnS<sub>2</sub>/ZnCdS heterostructure designed for the ultrasensitive detection of CA199. The unique heterojunction between SnS<sub>2</sub> and ZnCdS enhances photocurrent generation by effectively suppressing charge recombination and improving charge separation. Furthermore, the flower-like morphology of the heterostructure further boosts light absorption and photogenerated carrier transport, resulting in significantly enhanced sensor performance. This label-free PEC immunosensor exhibits outstanding stability, reproducibility and selectivity, with a broad detection range from 0.01 to 1000 U/mL and an ultra-low detection limit of 1.00 × 10<sup>-3</sup> U/mL. These features demonstrate the potential of this sensor as a powerful tool for sensitive CA199 detection, offering promising applications in cancer diagnostics and monitoring.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1584456"},"PeriodicalIF":4.3000,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12187654/pdf/","citationCount":"0","resultStr":"{\"title\":\"Ultrasensitive photoelectrochemical immunosensor based on floral cluster SnS<sub>2</sub>/ZnCdS heterostructure for the detection of CA199.\",\"authors\":\"Hui Zhou, Qingqing Guo, Xin Zhang, Tingting Chu, Wen Zhang, Qing Liu, Linlin Cao\",\"doi\":\"10.3389/fbioe.2025.1584456\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The early and accurate detection of tumor markers is crucial for cancer diagnosis, prognosis, and treatment monitoring. Carbohydrate antigen 199 (CA199), as a key biomarker of pancreatic, gastric, and colorectal cancers, is widely used in the clinical management. The development of sensitive, rapid and cost-effective detection methods for CA199 is of paramount importance in improving early detection rates and patient outcomes. In this study, we present a novel photoelectrochemical (PEC) immunosensor based on a SnS<sub>2</sub>/ZnCdS heterostructure designed for the ultrasensitive detection of CA199. The unique heterojunction between SnS<sub>2</sub> and ZnCdS enhances photocurrent generation by effectively suppressing charge recombination and improving charge separation. Furthermore, the flower-like morphology of the heterostructure further boosts light absorption and photogenerated carrier transport, resulting in significantly enhanced sensor performance. This label-free PEC immunosensor exhibits outstanding stability, reproducibility and selectivity, with a broad detection range from 0.01 to 1000 U/mL and an ultra-low detection limit of 1.00 × 10<sup>-3</sup> U/mL. These features demonstrate the potential of this sensor as a powerful tool for sensitive CA199 detection, offering promising applications in cancer diagnostics and monitoring.</p>\",\"PeriodicalId\":12444,\"journal\":{\"name\":\"Frontiers in Bioengineering and Biotechnology\",\"volume\":\"13 \",\"pages\":\"1584456\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2025-06-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12187654/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Bioengineering and Biotechnology\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.3389/fbioe.2025.1584456\",\"RegionNum\":3,\"RegionCategory\":\"工程技术\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1584456","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

肿瘤标志物的早期准确检测对肿瘤的诊断、预后和治疗监测至关重要。碳水化合物抗原199 (CA199)作为胰腺癌、胃癌和结直肠癌的关键生物标志物,被广泛应用于临床治疗。开发敏感、快速、经济的CA199检测方法对于提高早期检出率和患者预后至关重要。在这项研究中,我们提出了一种基于SnS2/ZnCdS异质结构的新型光电化学(PEC)免疫传感器,用于CA199的超灵敏检测。SnS2和ZnCdS之间独特的异质结通过有效抑制电荷复合和改善电荷分离来增强光电流的产生。此外,异质结构的花状形态进一步促进了光吸收和光生载流子输运,从而显著提高了传感器的性能。该无标记PEC免疫传感器具有出色的稳定性、重复性和选择性,检测范围为0.01 ~ 1000 U/mL,超低检出限为1.00 × 10-3 U/mL。这些特性证明了该传感器作为敏感CA199检测的强大工具的潜力,在癌症诊断和监测中提供了有前途的应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Ultrasensitive photoelectrochemical immunosensor based on floral cluster SnS2/ZnCdS heterostructure for the detection of CA199.

The early and accurate detection of tumor markers is crucial for cancer diagnosis, prognosis, and treatment monitoring. Carbohydrate antigen 199 (CA199), as a key biomarker of pancreatic, gastric, and colorectal cancers, is widely used in the clinical management. The development of sensitive, rapid and cost-effective detection methods for CA199 is of paramount importance in improving early detection rates and patient outcomes. In this study, we present a novel photoelectrochemical (PEC) immunosensor based on a SnS2/ZnCdS heterostructure designed for the ultrasensitive detection of CA199. The unique heterojunction between SnS2 and ZnCdS enhances photocurrent generation by effectively suppressing charge recombination and improving charge separation. Furthermore, the flower-like morphology of the heterostructure further boosts light absorption and photogenerated carrier transport, resulting in significantly enhanced sensor performance. This label-free PEC immunosensor exhibits outstanding stability, reproducibility and selectivity, with a broad detection range from 0.01 to 1000 U/mL and an ultra-low detection limit of 1.00 × 10-3 U/mL. These features demonstrate the potential of this sensor as a powerful tool for sensitive CA199 detection, offering promising applications in cancer diagnostics and monitoring.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Frontiers in Bioengineering and Biotechnology
Frontiers in Bioengineering and Biotechnology Chemical Engineering-Bioengineering
CiteScore
8.30
自引率
5.30%
发文量
2270
审稿时长
12 weeks
期刊介绍: The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs. In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信